ESC Premium Access

Guideline Adherence - Results from ESC CRT Survey II with 11088 patients

Topic: Resynchronisation therapy

Congress Presentation

6 more presentations in this session

Effect of QRS duration Normalized for Left Ventricular Size on Cardiac Resynchronization Therapy in Heart Failure Patients with a Narrow (<130 ms) QRS complex: A Subgroup Analysis of the EchoCRT Trial

Speaker: Doctor N. Varma (Cleveland, US)


REDEFINE trial: a double-blind, randomized trial with losartan to study RV dysfunction after repair of tetralogy of Fallot

Speaker: Doctor J. Bokma (Amsterdam, NL)


A Randomized Controlled Trial Evaluating the Efficacy of Long-term Use of Beta-blocker in Patients with ST-segment Elevation Myocardial Infarction treated with Primary Percutaneous Coronary Interventi

Speaker: Mr H. Watanabe (Wakayama, JP)


Efficacy and Safety of Evolocumab Compared With Continued Lipoprotein Apheresis: Results of a Randomised, Controlled, Open-Label Study

Speaker: Doctor P. Moriarty (Kansas City, US)


Intensive Longterm Prevention Program vs. Usual Care After Acute Myocardial Infarctions - The IPP study

Speaker: Professor H. Wienbergen (Bremen, DE)


Access the full session

Late-Breaking Science Posters

Speakers: Doctor N. Varma, Doctor J. Bokma, Mr H. Watanabe, Doctor P. Moriarty, Professor H. Wienbergen

About the event


ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb